Search

Search Results
Results 17091 - 17100 of 17221 for Active treatment
  • Galvus
    Drug - 1 Dec 2024
    Consumer Medicine Information (CMI) about Galvus intended for persons living in Australia.
  • Lasix and Lasix High Dose
    Drug - 26 Nov 2024
    Consumer Medicine Information (CMI) about Lasix and Lasix High Dose intended for persons living in Australia.
  • Toujeo
    Drug - 22 Oct 2024
    Consumer Medicine Information (CMI) about Toujeo intended for persons living in Australia.
  • Resonium A
    Drug - 17 Oct 2024
    Consumer Medicine Information (CMI) about Resonium A intended for persons living in Australia.
  • Nordip
    Drug - 15 Oct 2024
    Consumer Medicine Information (CMI) about Nordip intended for persons living in Australia.
  • Rapid thermal stability screening of monoclonal antibody drug products with RS-DSC
    White Paper - 10 Oct 2024
    Learn how TA Instruments' RS-DSC enables rapid thermal stability screening of monoclonal antibody drug products.
  • What are the safety considerations in developing ADCs?
    White Paper - 3 Oct 2024
    Learn all about ADCs; what they are, what are their research applications, and what safety considerations should be considered for developing ADCs.
  • Livtencity
    Drug - 3 Oct 2024
    Consumer Medicine Information (CMI) about Livtencity intended for persons living in Australia.
  • Revolutionizing NMR: Bringing advanced spectroscopy from the basement to the benchtop
    White Paper - 21 Aug 2024
    This article explores the revolutionary advancements in benchtop NMR instrumentation, which have brought this sophisticated analytical technique out of specialized facilities and into everyday...
  • ZolaCos CP
    Drug - 30 Jul 2024
    Consumer Medicine Information (CMI) about ZolaCos CP intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback